Rapaflo (silodosin) Disease Interactions
There are 3 disease interactions with Rapaflo (silodosin):
Silodosin (Includes Rapaflo) ↔ hepatic impairment
Severe Potential Hazard, Moderate plausibility. Applies to: Liver Disease
The use of silodosin is contraindicated in patients with severe hepatic impairment. No dosage adjustment is needed in patients with mild or moderate hepatic impairment.
Silodosin (Includes Rapaflo) ↔ severe renal impairment
Severe Potential Hazard, Moderate plausibility. Applies to: Renal Dysfunction
The use of silodosin is contraindicated in patients with severe renal impairment (CrCl < 30 mL/min). Caution and regular monitoring is recommended in patients with moderate renal impairment as the plasma concentrations can increase three times higher when compared with subjects with normal renal function. Dose should be reduced to 4 mg/day in patients with moderate renal impairment.
Antiadrenergic agents (Includes Rapaflo) ↔ cataracts
Moderate Potential Hazard, Moderate plausibility. Applies to: Cataracts
Intraoperative Floppy Iris Syndrome has been observed during cataract surgery in some patients on or previously treated with antiadrenergic agents. If a patient is undergoing cataract surgery, the ophthalmologist should be prepared for possible modifications of the surgical technique (iris hooks, iris dilator rings). There does not appear to be a benefit in stopping antiadrenergic agents therapy prior to the cataracts surgery.
Rapaflo (silodosin) drug interactions
There are 571 drug interactions with Rapaflo (silodosin)
Rapaflo (silodosin) alcohol/food interactions
There are 2 alcohol/food interactions with Rapaflo (silodosin)
More about Rapaflo (silodosin)
- Rapaflo Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 89 Reviews
- Generic Availability
- Drug class: antiadrenergic agents, peripherally acting
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.